Phillips-Moore Julie S, Talley Nicholas J, Jones Michael P
Sydney Essential Health, Sydney, NSW, Australia.
Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.
Health Psychol Open. 2015 Jan 28;2(1):2055102914564583. doi: 10.1177/2055102914564583. eCollection 2015 Jan.
Hypnotherapy has been reported as being beneficial in the treatment of irritable bowel syndrome (IBS). We aimed to test the hypothesis that patients with IBS treated 'holistically' by hypnosis (i.e. by combined psychological and physiological symptom imagery) would have greater improvement in their IBS symptoms than patients treated by hypnosis using standard 'gut-directed' hypnotherapy, and both would be superior to simple relaxation therapy.
Patients ( = 51) with Rome II criteria were randomised to 'individualised' (holistic) hypnotherapy, standard 'gut-directed' hypnotherapy or relaxation therapy for a period of 11 weeks with two follow-up assessments at 2 weeks and at 3 months after the completion of the trial. The primary outcome was bowel symptom severity scale (BSSS).
All the participants in this study improved their IBS symptoms (pain, bloating, constipation and diarrhoea) and physical functioning at the end of the treatment from baseline, but this was not significantly different across the treatment arms.
Neither 'individualised' nor 'gut-directed' hypnotherapy is superior to relaxation therapy in IBS.
有报道称催眠疗法对肠易激综合征(IBS)的治疗有益。我们旨在验证以下假设:通过催眠“整体”治疗(即结合心理和生理症状意象)的IBS患者,其IBS症状的改善程度将大于使用标准“肠道定向”催眠疗法治疗的患者,且两者均优于单纯的放松疗法。
符合罗马II标准的51例患者被随机分为“个体化”(整体)催眠疗法组、标准“肠道定向”催眠疗法组或放松疗法组,为期11周,并在试验结束后2周和3个月进行两次随访评估。主要结局指标为肠道症状严重程度量表(BSSS)。
本研究中所有参与者在治疗结束时,其IBS症状(疼痛、腹胀、便秘和腹泻)及身体功能较基线均有所改善,但各治疗组间无显著差异。
在IBS治疗中,“个体化”或“肠道定向”催眠疗法均不优于放松疗法。